CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling.
Xia FangChiqi ChenFangzhen XiaZhuo YuYaping ZhangFeifei ZhangHao GuJiangbo WanXiaocui ZhangWei WengCheng Cheng ZhangGuo-Qiang ChenAibing LiangLi XieJunke ZhengPublished in: Journal of hematology & oncology (2016)
The surface immune molecule CD274 plays a critical role in the proliferation of LICs. The CD274/JNK/Cyclin D2 pathway promotes the cell cycle entry of LICs, which may serve as a novel therapeutic target for the treatment of leukemia.